text: 24975194_7	RESULTS: Treatment with CRE (0.25, 0.5, and 1 mg/mL) resulted in inhibited levels of protein expression of lipopolysaccharide- (LPS-) induced iNOS, COX-2, NF-kB, and MAPKs (ERK, JNK, and p38) as well as production of TNF-a, IL-1b, IL-6, NO, and PGE2 induced by LPS.